Latanoprost+timolol Macarthys Laboratories

Timolol maleate and Latanoprost, the active ingredient in Latanoprost+timolol Macarthys Laboratories, is a beta blocker and prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure in patients with open‑angle glaucoma and ocular hypertension.

GNH USA supplies Latanoprost+timolol Macarthys Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost+timolol is indicated for conditions involving elevated intra‑ocular pressure, primarily within the glaucoma and ocular hypertension disease families.

- Open-angle glaucoma: reduces intra‑ocular pressure to slow optic nerve damage. - Ocular hypertension: lowers eye pressure to prevent progression to glaucoma. - Secondary open-angle glaucoma: helps control pressure when beta‑blocker monotherapy is insufficient.

The following adverse reactions have been reported with the combination ophthalmic solution.

Common Side Effects: - Eye irritation: mild burning or stinging after instillation. - Blurred vision: temporary visual disturbance. - Redness of the eye: conjunctival hyperemia. - Itching or discomfort: ocular pruritus. - Dry eye sensation: reduced tear film stability. - Foreign body sensation: feeling of something in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: angioedema or anaphylaxis. - Marked bradycardia: significant slowing of heart rate. - Bronchospasm: airway constriction, especially in asthmatic patients. - Systemic hypotension: low blood pressure causing dizziness. - Worsening of asthma or COPD symptoms. - Ocular inflammation: uveitis or keratitis.

Before prescribing or dispensing, consider the following safety measures.

- Assess cardiovascular status: evaluate for bradycardia or heart block prior to use. - Screen for respiratory disease: avoid in patients with uncontrolled asthma or severe COPD. - Monitor for ocular allergies: discontinue if severe irritation or allergic response occurs. - Check sulfonamide sensitivity: avoid if the formulation contains sulfonamide preservatives and the patient is allergic. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost+timolol may interact with other systemic or ocular medications.

Major Interactions (Avoid): - Non‑selective beta‑blockers (e.g., propranolol): additive systemic beta‑blockade. - Calcium channel blockers (e.g., verapamil): may enhance bradycardia. - Other intra‑ocular pressure‑lowering agents (e.g., pilocarpine): risk of excessive pressure reduction.

Moderate Interactions (Monitor Closely): - Systemic antihypertensives: monitor blood pressure for additive effects. - Bronchodilators (e.g., albuterol): may reduce timolol efficacy. - MAO inhibitors: potential for increased ocular side effects.